Key facts
- This page summarizes Chris Terrill's Form 4 filing for TERMINIX GLOBAL HOLDINGS INC.
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 14 Oct 2022, 18:53.
Chris Terrill - 12 Oct 2022 Form 4 Insider Report for TERMINIX GLOBAL HOLDINGS INC
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 12 Oct 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 14 Oct 2022, 18:53:33 UTC
- Prior SEC filing
- 09 Jun 2022
- Next SEC filing
- 03 Mar 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Dirk R. Gardner, Attorney In Fact for Chris S. Terrill
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Chris Terrill filed Form 4 for TERMINIX GLOBAL HOLDINGS INC on 14 Oct 2022.
Change
- Previous filing in this sequence was filed on 09 Jun 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TMX
transaction
Common Stock
Disposed to Issuer
- Transaction value
- Shares
- -5,526
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 12 Oct 2022
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Chris Terrill is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 1 footnote
Footnote F1
Represents shares of Terminix Global Holdings, Inc. ("Terminix") common stock disposed of in connection with the Agreement and Plan of Merger, dated as of December 13, 2021, as amended by Amendment No. 1 to the Agreement and Plan of Merger, dated as of March 14, 2022 (the "Merger Agreement"), by and among Terminix, Rentokil Initial plc ("Rentokil Initial") and certain of Rentokil Initial's subsidiaries. In accordance with the Merger Agreement, at the First Effective Time (as defined in the Merger Agreement), each share of Terminix common stock (other than certain excluded shares as described in the Merger Agreement) was converted into the right to receive either: (x) 1.4899 American depositary shares of Rentokil Initial ("Rentokil Initial ADSs"); or (y) $34.57 in cash and 0.1447 Rentokil Initial ADSs.
SEC remarks
In connection with the transaction, the reporting person ceased to be a Section 16 reporting person.